These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 2461889)
1. Interferon-associated lymphocyte 2',5'-oligoadenylate synthetase in acute and chronic viral hepatitis. Heathcote J; Kim YI; Yim CK; LeBrocq J; Read SE Hepatology; 1989 Jan; 9(1):105-9. PubMed ID: 2461889 [TBL] [Abstract][Full Text] [Related]
2. [2'-5' oligoadenylate synthetase activity in patients with acute viral hepatitis and chronic type B hepatitis, and its clinical significance]. Komiyama T; Akaike M; Satomura K; Okumura H Nihon Ika Daigaku Zasshi; 1991 Jun; 58(3):262-72. PubMed ID: 1715348 [TBL] [Abstract][Full Text] [Related]
3. 2',5'-Oligoadenylate synthetase activity in the liver and peripheral blood mononuclear cells of chronic hepatitis patients. Ogawa Y Gastroenterol Jpn; 1988 Jun; 23(3):279-86. PubMed ID: 2456963 [TBL] [Abstract][Full Text] [Related]
4. Relationship of the effects of interferon on chronic hepatitis B and the induction of 2',5'-oligoadenylate synthetase. Nishiguchi S; Kuroki T; Otani S; Takeda T; Hirota S; Shimizu Y; Nakajima S; Saito S; Shiomi S; Kobayashi K Hepatology; 1989 Jul; 10(1):29-33. PubMed ID: 2472340 [TBL] [Abstract][Full Text] [Related]
5. Detection of 2',5' oligoadenylate synthetase activity in acute viral hepatitis with special reference to histologic features in the acute stage. Okuno T; Shindo M; Arai K; Matsumoto M; Takeda M; Kashima K; Sokawa Y Gastroenterol Jpn; 1991 Apr; 26(2):162-9. PubMed ID: 1710193 [TBL] [Abstract][Full Text] [Related]
6. Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life. Ikeda T; Lever AM; Thomas HC Hepatology; 1986; 6(5):962-5. PubMed ID: 2428724 [TBL] [Abstract][Full Text] [Related]
7. Elevated levels of 2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells and serum during acute exacerbation of chronic hepatitis B. Shindo M; Okuno T; Arai K; Matsumoto M; Takeda M; Takino T; Sokawa Y Hepatology; 1989 May; 9(5):715-9. PubMed ID: 2468593 [TBL] [Abstract][Full Text] [Related]
8. Activities of 2'-5'oligoadenylate synthetase in peripheral blood mononuclear cells of patients with viral hepatitis, and chronic type B hepatitis during interferon therapy. Sugawara T; Matsushima T; Miyazaki T; Toyota J; Fujii N; Minagawa T Jpn J Med; 1986 May; 25(2):144-8. PubMed ID: 3747259 [TBL] [Abstract][Full Text] [Related]
9. [Mechanisms of the effect of interferon (IFN) therapy in patients with type B and C chronic hepatitis]. Karino Y Hokkaido Igaku Zasshi; 1993 May; 68(3):297-309. PubMed ID: 7686526 [TBL] [Abstract][Full Text] [Related]
10. Serum 2',5'-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis B. Shindo M; Okuno T; Matsumoto M; Takeda M; Takino T; Sokawa J; Iwata A; Sokawa Y Hepatology; 1988; 8(2):366-70. PubMed ID: 2451634 [TBL] [Abstract][Full Text] [Related]
11. Indomethacin enhances serum 2'5'-oligoadenylate synthetase in patients with hepatitis B and C virus chronic active hepatitis. Andreone P; Cursaro C; Gramenzi A; Buzzi A; Miniero R; Sprovieri G; Gasbarrini G J Hepatol; 1994 Dec; 21(6):984-8. PubMed ID: 7699263 [TBL] [Abstract][Full Text] [Related]
12. 2'5' Oligoadenylate synthetase assay in human diseases. Its clinical value in viral liver diseases. Chousterman S; Chousterman M; Poitrine A; Chaput JC; Thang MN Prog Clin Biol Res; 1985; 202():431-8. PubMed ID: 3008173 [No Abstract] [Full Text] [Related]
13. [Activation of the interferon system enzymes by recombinant alpha2-interferon in patients with chronic hepatitis B]. Sokolova TM; Bugaeva NP; Suetina IA; Ershov FI; Ketiladze ES Antibiot Khimioter; 1989 Jun; 34(6):472-5. PubMed ID: 2552947 [TBL] [Abstract][Full Text] [Related]
14. Serum 2',5'-oligoadenylate synthetase concentrations in acute and chronic hepatitis C. Yang PM; Wang JT; Chiang BL; Lai MY; Chen DS J Formos Med Assoc; 1997 May; 96(5):314-9. PubMed ID: 9170817 [TBL] [Abstract][Full Text] [Related]
15. 2',5'-Oligoadenylate synthetase activity in peripheral blood lymphocytes as a clinical marker in interferon therapy for chronic hepatitis B. Furuta M; Akashi K; Nakamura Y; Matsumoto K; Yamaguchi H; Takamatsu S; Shimizu T J Interferon Res; 1987 Feb; 7(1):111-9. PubMed ID: 3585079 [TBL] [Abstract][Full Text] [Related]
16. Elevation of 2',5'-oligoadenylate synthetase activity and HLA-I associated beta 2-microglobulin in response to recombinant interferon-gamma administration in chronic HBeAg-positive hepatitis. Quiroga JA; Mora I; Porres JC; CarreƱo V J Interferon Res; 1988 Dec; 8(6):755-63. PubMed ID: 3148006 [TBL] [Abstract][Full Text] [Related]
17. Role of 2'-5'-oligoadenylate synthetase in gamma-interferon-mediated growth inhibition of A431 cells. Kumar R; Mendelsohn J Cancer Res; 1989 Sep; 49(18):5180-4. PubMed ID: 2504485 [TBL] [Abstract][Full Text] [Related]
18. Effects of interferon on intrahepatic human leukocyte antigens and lymphocyte subsets in patients with chronic hepatitis B and C. Hayata T; Nakano Y; Yoshizawa K; Sodeyama T; Kiyosawa K Hepatology; 1991 Jun; 13(6):1022-8. PubMed ID: 1711000 [TBL] [Abstract][Full Text] [Related]
19. Relationship of HLA protein display to activation of 2-5A synthetase in HBe antigen or anti-HBe positive chronic HBV infection. Ikeda T; Pignatelli M; Lever AM; Thomas HC Gut; 1986 Dec; 27(12):1498-501. PubMed ID: 3804026 [TBL] [Abstract][Full Text] [Related]